Abstract
The American Heart Association Scientific Sessions were held in Orlando on November 7–15, 2015. The meeting attracted more than 18,000 participants, including physicians, research scientists, students, and paramedical personnel, from more than 100 countries. Sessions over the 5 days included a comprehensive and unparalleled education delivered via more than 5,000 presentations, with 1,000 invited faculty members and 4,000 abstract presentations from the world leaders in cardiovascular disease. It also displayed the newest cardiovascular technology and resources by more than 200 exhibitors. There were 19 trials scheduled in 6 late-breaking clinical trial sessions. The Systolic Blood Pressure Intervention Trial (SPRINT) aimed to determine the most appropriate targets for the systolic blood pressure among persons without diabetes. A total of 9,361 persons with systolic blood pressure of ≥130 mmHg and an increased cardiovascular risk, but without diabetes, were randomly assigned to a target systolic blood pressure of
| Original language | English |
|---|---|
| Pages (from-to) | 51-57 |
| Number of pages | 7 |
| Journal | Circulation Journal |
| Volume | 80 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2015 Dec 25 |
Fingerprint
Keywords
- American heart association
- Japanese circulation society
- Late-breaking clinical trials
- Scientific sessions
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
Report of the american heart association (AHA) scientific sessions 2015, Orlando. / Aizawa, Yoshiyasu; Kimura, Mai; Kohno, Takashi; Fujita, Jun; Fukuda, Keiichi.
In: Circulation Journal, Vol. 80, No. 1, 25.12.2015, p. 51-57.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Report of the american heart association (AHA) scientific sessions 2015, Orlando
AU - Aizawa, Yoshiyasu
AU - Kimura, Mai
AU - Kohno, Takashi
AU - Fujita, Jun
AU - Fukuda, Keiichi
PY - 2015/12/25
Y1 - 2015/12/25
N2 - The American Heart Association Scientific Sessions were held in Orlando on November 7–15, 2015. The meeting attracted more than 18,000 participants, including physicians, research scientists, students, and paramedical personnel, from more than 100 countries. Sessions over the 5 days included a comprehensive and unparalleled education delivered via more than 5,000 presentations, with 1,000 invited faculty members and 4,000 abstract presentations from the world leaders in cardiovascular disease. It also displayed the newest cardiovascular technology and resources by more than 200 exhibitors. There were 19 trials scheduled in 6 late-breaking clinical trial sessions. The Systolic Blood Pressure Intervention Trial (SPRINT) aimed to determine the most appropriate targets for the systolic blood pressure among persons without diabetes. A total of 9,361 persons with systolic blood pressure of ≥130 mmHg and an increased cardiovascular risk, but without diabetes, were randomly assigned to a target systolic blood pressure of
AB - The American Heart Association Scientific Sessions were held in Orlando on November 7–15, 2015. The meeting attracted more than 18,000 participants, including physicians, research scientists, students, and paramedical personnel, from more than 100 countries. Sessions over the 5 days included a comprehensive and unparalleled education delivered via more than 5,000 presentations, with 1,000 invited faculty members and 4,000 abstract presentations from the world leaders in cardiovascular disease. It also displayed the newest cardiovascular technology and resources by more than 200 exhibitors. There were 19 trials scheduled in 6 late-breaking clinical trial sessions. The Systolic Blood Pressure Intervention Trial (SPRINT) aimed to determine the most appropriate targets for the systolic blood pressure among persons without diabetes. A total of 9,361 persons with systolic blood pressure of ≥130 mmHg and an increased cardiovascular risk, but without diabetes, were randomly assigned to a target systolic blood pressure of
KW - American heart association
KW - Japanese circulation society
KW - Late-breaking clinical trials
KW - Scientific sessions
UR - http://www.scopus.com/inward/record.url?scp=84951774704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951774704&partnerID=8YFLogxK
U2 - 10.1253/circj.CJ-15-1272
DO - 10.1253/circj.CJ-15-1272
M3 - Article
C2 - 26667369
AN - SCOPUS:84951774704
VL - 80
SP - 51
EP - 57
JO - Circulation Journal
JF - Circulation Journal
SN - 1346-9843
IS - 1
ER -